Ima Paydar
Papers
2
Total Citations
38
H-Index
2
About
Ima Paydar is a radiation oncologist whose research focuses on optimizing treatment for prostate cancer, particularly through advanced radiotherapy techniques. Her major contributions center on the use of stereotactic body radiation therapy (SBRT) as a less invasive alternative to brachytherapy for unfavorable prostate cancer. In her highly cited 2017 work (21 citations), Paydar demonstrated that combining intensity-modulated radiation therapy (IMRT) with an SBRT boost yields promising 3-year toxicity outcomes, offering a potential paradigm shift in managing high-risk disease. She also made critical contributions to clinical trial design through her 2016 study (17 citations), which revealed that proctitis can occur as early as one week post-SBRT—a finding that challenges conventional assessment timelines and improves patient quality-of-life monitoring. Paydar’s work is notable for its practical impact: by refining SBRT protocols and toxicity evaluation, she has helped advance less invasive, more precise prostate cancer treatments. Her research bridges the gap between technological innovation and real-world patient care, making her a key voice in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2